Stockreport

Atossa Genetics opens enrollment in mid-stage study of Endoxifen in breast cancer; shares up 5% premarket [Seeking Alpha]

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com
PDF Atossa Genetics opens enrollment in mid-stage study of Endoxifen in breast cancer; shares up 5% premarket [Read more]